Avalon Globocare (ALBT)

Feb 27, 2026, 5:30 PM EST - 18 days ago

Avalon GloboCare Announces Closing of up to $9.75 Million Private Placement Priced At-the-Market under Nasdaq Rules

Feb 26, 2026, 9:20 PM EST - 19 days ago

Avalon GloboCare Announces up to $9.75 Million Private Placement Priced At-the-Market under Nasdaq Rules

Feb 26, 2026, 10:09 AM EST - 20 days ago

Avalon GloboCare (ALBT) Stock Surges On AMD AI News

AMD

Jan 27, 2026, 8:01 AM EST - 7 weeks ago

Top 3 Real Estate Stocks Which Could Rescue Your Portfolio This Month

DEI HPP

Jan 21, 2026, 9:35 AM EST - 2 months ago

FDA Green Lights Avalon GloboCare's KetoAir Breathalyzer

Jan 12, 2026, 9:00 AM EST - 2 months ago

Avalon GloboCare Regains Compliance with Nasdaq Stockholders' Equity Requirement, Launches Marketing for Automated Generative AI Video Platform

Dec 30, 2025, 9:00 AM EST - 2 months ago

Avalon GloboCare Board Director Highlights RPM Interactive's Automated Generative AI Video Creation Platform in Interview with ProactiveInvestors.com

Dec 23, 2025, 10:00 AM EST - 3 months ago

E.F. Hutton Advises on RPM Interactive's Acquisition by Avalon GloboCare

Dec 15, 2025, 8:32 AM EST - 3 months ago

Myseum Completes Sale of Minority Stake in RPM Interactive for Approximately $6.5 Million in Avalon GloboCare Acquisition

MYSE

Dec 15, 2025, 8:30 AM EST - 3 months ago

Avalon GloboCare Acquires RPM Interactive, a Generative AI Software Company, in an All-Stock Transaction

Dec 1, 2025, 9:00 AM EST - 3 months ago

Avalon GloboCare Reports Q3 2025 Progress with KetoAir™, Holistic Health Initiatives, and International Expansion

Aug 28, 2025, 9:00 AM EDT - 7 months ago

Avalon GloboCare to Launch Online Sales of KetoAir Breathalyzer in the United Kingdom

Jul 28, 2025, 9:00 AM EDT - 8 months ago

Avalon GloboCare Enters into Distribution Agreement with Saga Health for KetoAir Targeting First Responders

Jul 14, 2025, 8:00 AM EDT - 8 months ago

Avalon GloboCare Announces Patent Issuance for Novel CAR-T and CAR-NK Cell Technology in Hong Kong

Jun 26, 2025, 8:00 AM EDT - 9 months ago

Avalon GloboCare and Qi Diagnostics Enter into Definitive Agreement to Co-Develop Real-Time Cannabis Breathalyzer for Detecting Potential Impaired Driving

Jun 17, 2025, 6:22 AM EDT - 9 months ago

Top 2 Real Estate Stocks Which Could Rescue Your Portfolio This Quarter

MKZR

Mar 12, 2025, 7:15 PM EDT - 1 year ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates JWN and ALBT on Behalf of Shareholders

JWN

Nov 18, 2024, 9:00 AM EST - 1 year ago

Avalon GloboCare Launches “BrAce for Impact" Affiliate Marketing Program for the KetoAir Breathalyzer Device

Oct 25, 2024, 9:00 AM EDT - 1 year ago

Avalon GloboCare and Qi Diagnostics Enter into Memorandum of Understanding for Proposed Co-Development of Real-Time Cannabis Breathalyzer for Detecting Potential Impaired Driving

Jul 31, 2024, 8:00 AM EDT - 1 year ago

Avalon's Laboratory Services MSO Launches DNA Testing Kit for Predisposition to Opioid Addiction

May 24, 2024, 5:00 PM EDT - 1 year ago

Avalon GloboCare Receives Notice from Nasdaq Regarding Delayed Quarterly Report

Apr 22, 2024, 9:00 AM EDT - 2 years ago

Avalon GloboCare Announces Launch of U.S. Sales of KetoAir Breathalyzer at the Hack Your Health by KetoCon 2024 Conference

Mar 28, 2024, 9:00 AM EDT - 2 years ago

Avalon GloboCare Extends Exclusivity Agreement to Distribute KetoAir Breathalyzer Device and AI-Enabled Software in North America, South America, United Kingdom and European Union

Dec 18, 2023, 9:00 AM EST - 2 years ago

Avalon GloboCare Engages ChtrBx, a Marketing and Branding Company, to Launch KetoAir in the US

Oct 4, 2023, 9:00 AM EDT - 2 years ago

Apple Approves Use of Avalon GloboCare's KetoAir Mobile Application

Sep 13, 2023, 9:15 AM EDT - 2 years ago

Avalon's Laboratory Services MSO Acquires California-Based Medical Supply Company and Proprietary FDA-Registered External Male Catheter Device

Aug 30, 2023, 9:00 AM EDT - 2 years ago

Avalon's Laboratory Services MSO Launches Innovative Laboratory Test for Tuberculosis

Aug 21, 2023, 9:00 AM EDT - 2 years ago

Avalon's Laboratory Services MSO Announces Expansion into Arizona

Jul 24, 2023, 9:00 AM EDT - 2 years ago

Avalon's Laboratory Services MSO Acquires Texas Lab with Significant Potential Growth

Jul 19, 2023, 9:00 AM EDT - 2 years ago

Avalon GloboCare's Laboratory Services MSO Signs Exclusive In-Network Lab Services Agreement Providing Significant Expansion Opportunity into 21 States

Jul 10, 2023, 9:00 AM EDT - 2 years ago

Avalon GloboCare Provides Update on New Commercial Strategy

Apr 27, 2023, 9:00 AM EDT - 3 years ago

Avalon GloboCare Reports Laboratory Services MSO Revenue of $14.7 Million and Net Income of $6.3 Million in 2022

Mar 3, 2023, 9:00 AM EST - 3 years ago

Avalon GloboCare to Participate in the 35th Annual Roth Conference

Feb 13, 2023, 9:00 AM EST - 3 years ago

Avalon GloboCare Announces Closing of Strategic Investment in Laboratory Services MSO, a Leading Clinical Diagnostics and Reference Laboratory Company

Jan 17, 2023, 9:00 AM EST - 3 years ago

Avalon GloboCare Announces Issuance of Key U.S. Patent for Multiple Novel QTY-Code Modified Cytokine and Chemokine Protein Receptor Molecules

Jan 11, 2023, 9:00 AM EST - 3 years ago

Avalon GloboCare Appoints Lourdes Felix, CEO of a Premier Addiction Treatment Company, to its Board of Directors

Jan 3, 2023, 9:00 AM EST - 3 years ago

Avalon GloboCare Announces the Deployment of Breakthrough Fusion Gene Map Technology

Dec 14, 2022, 9:00 AM EST - 3 years ago

Avalon GloboCare Announces $4 Million Private Placement of Preferred Stock with the Company's Chairman which Converts at a Significant Premium to Market; Proceeds to Support Acquisition of Laboratory Services

Dec 12, 2022, 9:00 AM EST - 3 years ago

Avalon GloboCare Continues its U.S. Centric Strategy with a New Proposed Board Composition in Preparation for Acquisition of Laboratory Services MSO, LLC

Nov 9, 2022, 4:00 PM EST - 3 years ago

Avalon GloboCare Announces NASDAQ Ticker Symbol Change from “AVCO” to “ALBT”